NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-OD-17-025 from the NIH Guide for Grants and Contracts
Notice NOT-OH-17-004 from the NIH Guide for Grants and Contracts
Notice NOT-OH-17-003 from the NIH Guide for Grants and Contracts
Notice NOT-RM-17-003 from the NIH Guide for Grants and Contracts
Notice NOT-RM-17-002 from the NIH Guide for Grants and Contracts
Notice NOT-RM-17-004 from the NIH Guide for Grants and Contracts
Notice NOT-DK-17-004 from the NIH Guide for Grants and Contracts
Notice NOT-DE-17-007 from the NIH Guide for Grants and Contracts
Notice NOT-OH-17-005 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-CA-17-014 from the NIH Guide for Grants and Contracts. The purpose of the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to encourage and retain outstanding graduate students who have demonstrated potential and interest in pursuing careers as independent cancer researchers. The award will facilitate the transition of talented graduate students into successful cancer research postdoctoral appointments, and provide opportunities for career development activities relevant to their long-term career goals of becoming independent cancer researchers.
Funding Opportunity RFA-AI-16-085 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to solicit bi-phasic research applications to support translational research focused on development of Multipurpose Prevention Technologies (MPTs) for prevention of sexually transmitted infections (STIs), human immunodeficiency virus (HIV) and/or unintended pregnancy. Applications must employ strategies that further the prevention of two or more STIs, an STI and Human Immunodeficiency Virus, or an STI and unintended pregnancies.
Funding Opportunity PAR-17-070 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIGMS R25 program is to support educational activities that complement and/or enhance the research training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development, Mentoring Activities, and Outreach.
Funding Opportunity RFA-CA-17-004 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to establish a PDXNet Data Commons and Coordinating Center (PDCCC). PDCCC will interact with and coordinate with the PDX (Patient-Derived Xenograft) Development and Trial Centers Research Network (PDXNet) comprised of four PDX Development and Trial Centers (PDTCs, to be supported by companion FOA, RFA-CA-17-003) in a collaborative network. The PDXNet is a National Cancer Institute (NCI) program established to coordinate collaborative, large-scale development and pre-clinical testing of targeted therapeutic agents in patient-derived models to advance the vision of cancer precision medicine. The goals for PDTCs include: development of new PDX models and methods for preclinical testing of single agents and drug combinations; and using the newly established models as well as other existing well-characterized PDX models for studies of drug responses. The PDCCC will serve as the coordinating and data analysis center of the PDXNet. It is expected that the outcomes of PDXNet research will be particularly important for the prioritization of combinations of agents in the portfolio of NCI Investigational New Drugs (NCI-IND agents), which are evaluated clinically in the NCIs Experimental Therapeutic Clinical Trials Network (ETCTN).
Funding Opportunity RFA-CA-17-003 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) solicits applications for PDX (patient-derived xenografts) Development and Trial Centers (PDTCs) to serve as the laboratory research units of the PDX Development and Trial Centers Research Network (PDXNet). The PDXNet is a National Cancer Institute (NCI) program established to coordinate collaborative, large-scale development and pre-clinical testing of targeted therapeutic agents in patient-derived models to advance the vision of cancer precision medicine.
Funding Opportunity RFA-DA-17-024 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages research that examines the optimization of multiple components of the care continuum, such as HIV testing (identification) status, linkage and retention in care, and viral suppression for individuals with HIV for substance abusing populations at high-risk and/or living with HIV. There is limited evidence for how strategies that are successful in targeting one part of the HIV care cascade (linkage to care) can be integrated with interventions for other behaviors (ART adherence, retention in care). Moreover, the need to understand how government policies related to financing and clinical recommendations affect care, along with professional norms and the policies and guidelines established within individual clinics or organized systems of care effect the care continuum and HIV clinical outcomes, are critical. This FOA requires that applications include an examination beyond patient-level outcomes alone to include provider practices, system or organizational capacities, policies, and protocols; and structural issues including national, state/provincial or local policies that affect access to substance use and/or HIV care.
Funding Opportunity PAR-17-068 from the NIH Guide for Grants and Contracts. The Maximizing Access to Research Careers (MARC) Undergraduate Student Training in Academic Research (U-STAR) program is designed to provide structured training programs to prepare high-achieving, underrepresented students for doctoral programs in biomedical research fields. Programmatic activities should include authentic research experiences, academic enhancements, skills development, and mentoring. The long-term goal of the program is to enhance the pool of underrepresented students earning baccalaureate and Ph.D. degrees in biomedical research fields and ultimately to contribute to the diversification of the nation's scientific workforce.
Notice NOT-MH-17-008 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-17-069 from the NIH Guide for Grants and Contracts. The purpose of the NCI Career Transition Award to Promote Diversity program is to assist a postdoctoral fellow's transition to positions of assistant professor or equivalent and initiate a successful biomedical career as an independent research scientist. To this end, the Diversity Training Branch (DTB), the Center to Reduce Cancer Health Disparities (CRCHD) (http://crchd.cancer.gov/) invites applications from research scientists in postdoctoral positions or equivalent who are from backgrounds underrepresented in biomedical, behavioral, clinical, and/or social sciences. This award will provide "protected time" through salary and research support for 3 years for recipients to develop and receive support for their initial cancer research program.
Notice NOT-HL-16-477 from the NIH Guide for Grants and Contracts
Notice NOT-DA-17-005 from the NIH Guide for Grants and Contracts